环孢素诱导的高血压。 - Suppr

Suppr

超能文献

Cyclosporin-induced hypertension.

作者信息

Cífková R, Hallen H

机构信息

Institute for clinical and Experimental Medicine, Prague, Czech Republic.

出版信息

J Hypertens. 2001 Dec;19(12):2283-5. doi: 10.1097/00004872-200112000-00025.

DOI:10.1097/00004872-200112000-00025

PMID:11725176

Abstract

摘要

相似文献

Cyclosporin-induced hypertension.

J Hypertens. 2001 Dec;19(12):2283-5. doi: 10.1097/00004872-200112000-00025.

Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation.

Nephrol Dial Transplant. 2001;16 Suppl 1:121-4. doi: 10.1093/ndt/16.suppl_1.121.

Posttransplant hypertension.

Transplant Proc. 1998 Aug;30(5):2009-11. doi: 10.1016/s0041-1345(98)00513-2.

Mechanisms and consequences of arterial hypertension after renal transplantation.

Transplantation. 2001 Sep 27;72(6 Suppl):S9-12. doi: 10.1097/00007890-200109271-00004.

[Is it possible to prevent kidney problems caused by immunosuppression?].

Duodecim. 2000;116(5):511-9.

Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus.

Transplant Proc. 1998 Jun;30(4):1240-2. doi: 10.1016/s0041-1345(98)00226-7.

Cardiac hypertrophy postliver transplantation: a role for FK506 and cyclosporine A?

Transplantation. 2002 Sep 27;74(6):757-8. doi: 10.1097/00007890-200209270-00004.

Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation.

Bone Marrow Transplant. 1997 Dec;20(12):1095-8. doi: 10.1038/sj.bmt.1701027.

Immunosuppressant-induced nephropathy: pathophysiology, incidence and management.

Drug Saf. 1999 Dec;21(6):471-88. doi: 10.2165/00002018-199921060-00004.

Cyclosporin A-associated hypertension--pathomechanisms and clinical consequences.

Nephrol Dial Transplant. 1997 Mar;12(3):395-8. doi: 10.1093/oxfordjournals.ndt.a027761.

引用本文的文献

Managing the Patient with Psoriasis and Metabolic Comorbidities.

Am J Clin Dermatol. 2024 Jul;25(4):527-540. doi: 10.1007/s40257-024-00857-0. Epub 2024 May 15.

[Recommendations when switching therapy from immunosuppressive drugs to dupilumab in patients with atopic dermatitis].

Hautarzt. 2021 Apr;72(4):321-327. doi: 10.1007/s00105-020-04720-1.

[Austrian Consensus on High Blood Pressure 2019].

Wien Klin Wochenschr. 2019 Nov;131(Suppl 6):489-590. doi: 10.1007/s00508-019-01565-0.

Secondary hypertension: interfering substances.

J Clin Hypertens (Greenwich). 2008 Jul;10(7):556-66. doi: 10.1111/j.1751-7176.2008.07758.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Cyclosporin-induced hypertension.

J Hypertens. 2001 Dec;19(12):2283-5. doi: 10.1097/00004872-200112000-00025.

Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation.

Nephrol Dial Transplant. 2001;16 Suppl 1:121-4. doi: 10.1093/ndt/16.suppl_1.121.

Posttransplant hypertension.

Transplant Proc. 1998 Aug;30(5):2009-11. doi: 10.1016/s0041-1345(98)00513-2.

Mechanisms and consequences of arterial hypertension after renal transplantation.

Transplantation. 2001 Sep 27;72(6 Suppl):S9-12. doi: 10.1097/00007890-200109271-00004.

[Is it possible to prevent kidney problems caused by immunosuppression?].

Duodecim. 2000;116(5):511-9.

Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus.

Transplant Proc. 1998 Jun;30(4):1240-2. doi: 10.1016/s0041-1345(98)00226-7.

Cardiac hypertrophy postliver transplantation: a role for FK506 and cyclosporine A?

Transplantation. 2002 Sep 27;74(6):757-8. doi: 10.1097/00007890-200209270-00004.

Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation.

Bone Marrow Transplant. 1997 Dec;20(12):1095-8. doi: 10.1038/sj.bmt.1701027.

Immunosuppressant-induced nephropathy: pathophysiology, incidence and management.

Drug Saf. 1999 Dec;21(6):471-88. doi: 10.2165/00002018-199921060-00004.

Cyclosporin A-associated hypertension--pathomechanisms and clinical consequences.

Nephrol Dial Transplant. 1997 Mar;12(3):395-8. doi: 10.1093/oxfordjournals.ndt.a027761.

引用本文的文献

Managing the Patient with Psoriasis and Metabolic Comorbidities.

Am J Clin Dermatol. 2024 Jul;25(4):527-540. doi: 10.1007/s40257-024-00857-0. Epub 2024 May 15.

[Recommendations when switching therapy from immunosuppressive drugs to dupilumab in patients with atopic dermatitis].

Hautarzt. 2021 Apr;72(4):321-327. doi: 10.1007/s00105-020-04720-1.

[Austrian Consensus on High Blood Pressure 2019].

Wien Klin Wochenschr. 2019 Nov;131(Suppl 6):489-590. doi: 10.1007/s00508-019-01565-0.

Secondary hypertension: interfering substances.

J Clin Hypertens (Greenwich). 2008 Jul;10(7):556-66. doi: 10.1111/j.1751-7176.2008.07758.x.